BBNX

Beta Bionics, Inc.

• PR Newswire·13h ago

  Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth

• Seeking Alpha·2d ago

  Small-cap sell streaks: 10 stocks trapped longest in bearish Quant ratings

• PR Newswire·4d ago

  Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth

• PUBT·06/05 22:05

  Beta Bionics Chief Commercial Officer Mark Hopman disposes of 275 common shares for $3,385.25

• PUBT·06/05 22:05

  Beta Bionics director Christy Jones sells 2,811 shares worth $39,354

• TipRanks·06/03 20:55

  Beta Bionics management to meet with Piper Sandler

• Benzinga·06/02 13:09

  Beta Bionics Announces Near Real-Time Real-World Data On iLet Bionic Pancreas Is Now Publicly Available At betabionics.com/hcp/real-world-data

• PUBT·06/02 13:05

  Beta Bionics launches public near real-time real-world iLet Bionic Pancreas outcomes dashboard

• Dow Jones·05/27 17:42

  Beta Bionics Is Maintained at Buy by Goldman Sachs

• Dow Jones·05/27 17:42

  Beta Bionics Price Target Cut to $17.00/Share From $19.00 by Goldman Sachs

• Benzinga·05/27 17:32

  Goldman Sachs Maintains Buy on Beta Bionics, Lowers Price Target to $17

• TipRanks·05/27 10:23

  Beta Bionics price target lowered to $17 from $19 at Goldman Sachs

• PUBT·05/26 22:01

  Beta Bionics director Christy Jones disposes of 1,998 common shares worth $19,880.1

• PUBT·05/26 22:01

  Beta Bionics director Adam Lezack sells 1,998 common shares for $21,112.58

• TipRanks·05/22 21:00

  Beta Bionics Stockholders Approve Directors and Auditor Ratification